Europe Skin Graft Market
The European skin graft market includes the consolidated markets for France, Italy, France, Germany, United Kingdom, and rest of Europe. Europe occupies a significant position in the global skin graft market and is expected to register robust growth rate during the forecast period. The market in Germany is driven by focus on technological developments in medical devices industry, new product offerings by market players and government initiatives for cancer diagnostics and screening. In Germany, malignant melanoma, basal cell carcinoma, and squamous cell carcinoma are the three most common forms of skin cancer. Thus, high prevalence of these diseases supports the growth of the market. Furthermore, there are number of manufacturers in the Germany offering skin substitutes. For instance, Bioseed-S, is an autologous graft by BioTissue Technologies GmbH and Matriderm, an Xenogeneneic graft, is offered by Dr Suwelack Skin and HealthCare AG. The demand of tissues and organs for transplantation is found to be increasing in Germany. The German Organ Transplant Foundation reported a fall in the number of organ and tissues even though the demand is increasing. The government authorities are engaged in increasing its efforts on advertising and creating awareness about organ and tissue donation which will further help to an increase the number of donors thereby enabling the patients to undergo transplant at the earliest
Countries in the European regions were profoundly affected due to the COVID-19 pandemic. For instance, countries such as Italy, Spain, and France have reported the highest number of positive cases and have registered the maximum number of deaths in the first wave of COVID-19. Also, in second wave of COVID-19, the majority of the deaths were registered in these countries. Therefore, to control the spread of coronavirus, governments of various countries have implemented lockdown. Thus, it is having affected the medical services for various health conditions, and all the services were offered only for COVID-19 infected people. For instance, Mallinckrodt, a UK-based specialty pharmaceutical company will have to wait a bit longer for an FDA decision on its regenerative skin tissue therapy StrataGraft, as COVID-19 travel restrictions forced the delay of a manufacturing plant inspection. The countries with the highest estimated incidence rates of skin cancer in Europe were Switzerland, Norway and the Netherlands. However, the services for skin cancer treatment has reduced dramatically. In addition, various events for skin graft procedures, such as conferences, awareness campaigns, have been postponed. Furthermore, the trade for skin grafts has been reduced for the time being, which has resulted in a loss for various companies during this pandemic and forecasted year.
Strategic insights for the Europe Skin Graft provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 294.33 Million |
| Market Size by 2028 | US$ 494.53 Million |
| Global CAGR (2021 - 2028) | 7.7% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By Product
|
| Regions and Countries Covered | Europe
|
| Market leaders and key company profiles |
The geographic scope of the Europe Skin Graft refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.
The skin graft market in Europe is expected to grow from US$ 294.33 million in 2021 to US$ 494.53 million by 2028; it is estimated to grow at a CAGR of 7.7% from 2021 to 2028. 3D-printed skin grafts; 3D printing is an emerging field in the medical industry that is contributing to various technological innovations. It has allowed developers to design 3D-printed skin grafts by eliminating the need to create artificial grafts. In 2019, technological developments enabled Rensselaer Polytechnic Institute, New York researchers to innovate 3D-printing of living skin with complete blood vessels. It is expected that 3D-printed living skin will allow patients to undergo skin grafting without suffering secondary wounds created during surgical procedures. However, the 3D-printed living skin is under clinical trials, and much more work is needed to use 3D-printed living skin for human use. Significant progress has been made to use 3D-printed living skin to treat diabetes and pressure ulcers or wounds. It is also expected that 3D-printed living skin will reduce the risk of complications and address aesthetics concerns with more ease. According to the researchers for Rensselaer Polytechnic Institute, the 3D-printed living skin will be more like a fancy band-aid that will accelerate wound healing with much more reduced time. Thus, such innovations in skin grafts are likely to enhance the growth opportunities for market players to commercialize 3D-printed skin grafts and contribute to the growth of the market in the coming future.
Based on product, the market is segmented into autologous, allogeneic, xenogeneic, prosthetic, and isogeneic. In 2020, the autologous segment held the largest share of the market. Based on graft thickness, the market is divided into split-thickness, full-thickness and composite graft. In 2020, the split thickness segment held the largest share of the market. Based on equipment, the market is segmented into dermatome, general surgical instruments, consumables, and others
A few major primary and secondary sources referred to for preparing this report on the skin graft market in Europe are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are AVITA Medical
The Europe Skin Graft Market is valued at US$ 294.33 Million in 2021, it is projected to reach US$ 494.53 Million by 2028.
As per our report Europe Skin Graft Market, the market size is valued at US$ 294.33 Million in 2021, projecting it to reach US$ 494.53 Million by 2028. This translates to a CAGR of approximately 7.7% during the forecast period.
The Europe Skin Graft Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Skin Graft Market report:
The Europe Skin Graft Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Skin Graft Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Skin Graft Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Europe Skin Graft Market
